Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
102 hedge funds and large institutions have $441M invested in Myovant Sciences Ltd. in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 33 reducing their positions, and 19 closing their positions.
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
6% more funds holding
Funds holding: 96 → 102 (+6)
6% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 33
25% less call options, than puts
Call options by funds: $9.08M | Put options by funds: $12.1M
35% less capital invested
Capital invested by funds: $676M → $441M (-$235M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$15.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.7M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$8.35M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$8.28M |
| 5 |
O
OrbiMed
New York
|
+$6.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.4M |
| 2 |
VA
VR Adviser
New York
|
-$17.4M |
| 3 |
EP
Eversept Partners
New York
|
-$15.7M |
| 4 |
Millennium Management
New York
|
-$10.5M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.79M |
MYOV Hedge Fund Activity: Q3 2020 in Review
102 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q3 2020, worth a combined $441M — down 35% from $676M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MYOV positions and 19 closed out — a net gain of 7 holders — while 31 added to existing stakes and 33 trimmed.
The largest buyer was Norges Bank, adding an estimated $15.8M. The largest seller was Fidelity Investments, cutting an estimated $24.4M.
- 102 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q3 2020, up from 96 in Q2 2020.
- Funds reported $441M of Myovant Sciences Ltd. stock for Q3 2020, down 35% quarter-over-quarter.
- 26 funds opened new Myovant Sciences Ltd. positions in Q3 2020 and 19 closed out, a net change of +7 holders.
- The largest Myovant Sciences Ltd. buyer in Q3 2020 was Norges Bank, an estimated $15.8M added.
- The largest Myovant Sciences Ltd. seller in Q3 2020 was Fidelity Investments, an estimated $24.4M sold.
Based on aggregated 13F filings for Q3 2020.